Summary
To estimate the complement-activating property (CAP) of IgM rheumatoid factor (RF), which was purified from synovial fluids of patients with rheumatoid arthritis, in a reaction with each IgG subclass, the activation and binding of C4 in the classical pathway of complement by IgM RF was measured in an enzyme-linked immunosorbent assay using biotinylated F(ab')2 antibody to human C4. The CAP of IgM RF reacting with IgG3 was significantly higher than that of IgM RFs bound to the other IgG subclasses (P<0.01). These results suggest that IgM RF reacting with IgG3 in synovial fluid could induce a greater degree of complement-dependent inflammation in RA synovium than IgM RF reacting with other IgG subclasses.
Similar content being viewed by others
References
Normansell, D.E., Young, C.W.Jr. The IgG subclass specificity of anti IgG immunoglobulin rheumatoid factors Immunochemistry 1975, 12, 187–188.
Robbins, D.L., Wistar, R.Jr. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis. J Rheumatol 1985, 12, 437–443.
Robbins, D.L., Skilling, J., Benisek, W.F., Wistar, R. Jr. Estimation of the relative avidity of 19S IgM rheumatoid factor secreted by rheumatoid synovial cells for human IgG subclasses. Arthritis Rheum 1986, 29, 722–729.
Robbins, D.L., Benisek, W.F., Benjamini, E., Wistar, R. Jr. Differential reactivity of rheumatoid synovial cells and serum rheumatoid factor to human immunoglobulin G subclasses 1 and 3 and their CH3 domains in rheumatoid arthritis. Arthritis Rheum 1987, 30, 489–497.
Zvaifler, N.J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973, 16, 265–336.
Sato, Y., Sato, R., Watanabe, H., Kogure, a., Watanabe, K., Nishimaki, T., Kasukawa, R., Kuraya, M., Fujita, T. Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors. Ann Rheum Dis 1993, 52, 795–800.
Sabharwal, U.K., Vaughan, J.H., Fong, S., Bennett P.H., Carson, D.A., Curd, J.G. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum 1982, 25, 162–167.
Arnett, F.C., Edworthy, S.M., Bloch, D.A., MacShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A., Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L., Hunder, G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, 315–324.
Neucks, H.S., Robbins, D.L., Moore, T.L., Zuckner, J., Dorner, R.W. Hidden 19S rheumatoid factor in synovial fluid. J Rheumatol 1981, 8, 811–814.
Joseph, T.T., Schmid, F.R. Heterogenity among rheumatoid factors for complement fixation. J Immunol 1973, 110, 993–1002.
Christopher, J., Feigal, D.W. Robbins, D.L., Shapiro, R., Wiesner, K. Serum IgM and IgG rheumatoid factors and complement activation in extraarticular rheumatoid disease. J Rheumatol 1985, 12, 227–232.
Hoffman, W.L., Goldberg, M.S., Smiley, J.D. Immunoglobulin G3 subclass production by rheumatoid synovial tissue cultures. J Clin Invest 1982, 69, 136–144.
Watson, W.C., Cremer, M.A., Wooly, P.H., Townes, A.S. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis: Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 1986, 29, 1316–1321.
Wallance, A.L., Osler, A.G., Mayer, M. Quantitative studies of complement fixation. V. Estimation of complement-fixing potency of immune sera and its relation to antibody-nitrogen content. J Immunol 1950, 65, 661–673.
Stanley, S.L.Jr., Bischoff, J.K., Davie, J.M. Antigen-induced rheumatoid factors. Protein and carbohydrate antigens induce different rheumatoid factor response. J Immunol 1987, 139, 2936–2941.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, Y., Watanabe, H., Kogure, A. et al. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses. Clin Rheumatol 14, 425–428 (1995). https://doi.org/10.1007/BF02207676
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02207676